Ascletis Pharma Stock Price Prediction
| ASCLF Stock | USD 0.18 0.00 0.00% |
Oversold Vs Overbought
49
Oversold | Overbought |
Using Ascletis Pharma hype-based prediction, you can estimate the value of Ascletis Pharma from the perspective of Ascletis Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ascletis Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Ascletis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ascletis Pharma after-hype prediction price | USD 0.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ascletis |
Ascletis Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Ascletis Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ascletis Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Ascletis Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ascletis Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ascletis Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ascletis Pharma's historical news coverage. Ascletis Pharma's after-hype downside and upside margins for the prediction period are 0.01 and 3.87, respectively. We have considered Ascletis Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ascletis Pharma is out of control at this time. Analysis and calculation of next after-hype price of Ascletis Pharma is based on 3 months time horizon.
Ascletis Pharma Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ascletis Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ascletis Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ascletis Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 3.69 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.18 | 0.18 | 0.00 |
|
Ascletis Pharma Hype Timeline
Ascletis Pharma is presently traded for 0.18. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ascletis is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at 0.35%. %. The volatility of related hype on Ascletis Pharma is about 131785.71%, with the expected price after the next announcement by competition of 0.18. About 67.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.58. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ascletis Pharma recorded a loss per share of 0.03. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next expected press release will be in 5 to 10 days. Check out Ascletis Pharma Basic Forecasting Models to cross-verify your projections.Ascletis Pharma Related Hype Analysis
Having access to credible news sources related to Ascletis Pharma's direct competition is more important than ever and may enhance your ability to predict Ascletis Pharma's future price movements. Getting to know how Ascletis Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ascletis Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AKESF | Akeso, Inc | 0.00 | 0 per month | 3.86 | 0.13 | 12.00 | (7.89) | 41.83 | |
| ADYX | Adynxx Inc | 0.00 | 0 per month | 0.00 | 0.08 | 0.00 | 0.00 | 266.67 | |
| BCDAW | BioCardia | (0.0002) | 1 per month | 18.27 | 0.06 | 57.25 | (40.00) | 139.50 | |
| ADILW | Adial Pharmaceuticals WT | (0.01) | 1 per month | 25.95 | 0.1 | 95.66 | (55.00) | 199.49 |
Ascletis Pharma Additional Predictive Modules
Most predictive techniques to examine Ascletis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascletis using various technical indicators. When you analyze Ascletis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ascletis Pharma Predictive Indicators
The successful prediction of Ascletis Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ascletis Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ascletis Pharma based on analysis of Ascletis Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ascletis Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ascletis Pharma's related companies.
Story Coverage note for Ascletis Pharma
The number of cover stories for Ascletis Pharma depends on current market conditions and Ascletis Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ascletis Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ascletis Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Ascletis Pharma Short Properties
Ascletis Pharma's future price predictability will typically decrease when Ascletis Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ascletis Pharma often depends not only on the future outlook of the potential Ascletis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascletis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 B |
Complementary Tools for Ascletis Pink Sheet analysis
When running Ascletis Pharma's price analysis, check to measure Ascletis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascletis Pharma is operating at the current time. Most of Ascletis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascletis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascletis Pharma's price. Additionally, you may evaluate how the addition of Ascletis Pharma to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |